Delivery Order 36F79720D0104-36C26024F0134
- This is a firm-fixed-price delivery order awarded by the U.S. Department of Veterans Affairs (VA) to United Therapeutics Corp, a self-certified small disadvantaged business and manufacturer of pharmaceutical goods. The $88,161.72 order is for Tyvaso (treprostinil) inhalation solution, a drug used to treat pulmonary arterial hypertension. The delivery order was placed against United Therapeutics' $198 million Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs, which allows the...
- This is a firm fixed-price delivery order contract awarded by the U.S. Department of Veterans Affairs (VA) to United Therapeutics Corp, a self-certified small disadvantaged business and manufacturer of pharmaceutical goods. The contract, valued at $31,085.18, is for the supply of Tyvaso (treprostinil) inhalation solution, a medication used to treat pulmonary arterial hypertension. The contract is a delivery order placed against United Therapeutics' Federal Supply Schedule (FSS) contract for...
- This is a firm-fixed-price delivery order contract awarded by the U.S. Department of Veterans Affairs (VA) to United Therapeutics Corporation, a self-certified small disadvantaged business and manufacturer of pharmaceutical goods. The contract, valued at $32,063.20, is for the supply of Tyvaso (treprostinil) inhalation solution, a medication used to treat pulmonary arterial hypertension. The contract was awarded under United Therapeutics' Federal Supply Schedule (FSS) contract for...
- This is a delivery order for $16,391.56 awarded by the U.S. Department of Veterans Affairs (VA) to United Therapeutics Corporation, a self-certified small disadvantaged business and manufacturer of pharmaceutical goods. The order is for the drug Tyvaso (treprostinil) inhalation solution, a treatment for pulmonary arterial hypertension. The contract is issued under United Therapeutics' Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB) with the VA. United...
- This is a firm fixed price delivery order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to United Therapeutics Corp, a self-certified small disadvantaged business and manufacturer of pharmaceutical goods. The $16,391.56 order is for Tyvaso inhalation solution, one of United Therapeutics' core products used to treat pulmonary arterial hypertension. This delivery order is placed against United Therapeutics' $198 million Federal Supply Schedule (FSS) contract for...
- This is a firm-fixed-price delivery order awarded by the U.S. Department of Veterans Affairs (VA) to United Therapeutics Corp, a self-certified small disadvantaged business and manufacturer of pharmaceutical goods. The $14,693.62 order is for the supply of Tyvaso, a pulmonary arterial hypertension treatment, under United Therapeutics' $198 million Federal Supply Schedule contract for Pharmaceuticals and Drugs. This delivery order is part of a larger $50 million Blanket Purchase Agreement the...
- This is a firm-fixed-price delivery order worth $15,649.11 awarded by the U.S. Department of Veterans Affairs (VA) to United Therapeutics Corporation, a self-certified small disadvantaged business and manufacturer of pharmaceutical goods. The order is for the Tyvaso 64 MCG Oral Inhalation Kit, which is used to treat pulmonary arterial hypertension. The delivery order was awarded under United Therapeutics' $198 million Federal Supply Schedule contract for Pharmaceuticals and Drugs (FSS-61-IB)...
- This is a $75,656.34 firm-fixed-price delivery order awarded by the U.S. Department of Veterans Affairs (VA) to United Therapeutics Corp, a self-certified small disadvantaged business and manufacturer of pharmaceutical goods. The order is for a 6-month supply of Tyvaso (treprostinil) 0.6mg/mL inhalation solution refill kits. This delivery order is placed against United Therapeutics' $50 million Blanket Purchase Agreement (BPA) with the VA National Acquisition Center for the supply of its...
- This is a delivery order issued by the Department of Veterans Affairs (VA) Veterans Health Administration to United Therapeutics Corp, a small disadvantaged business and manufacturer of pharmaceuticals. The order is for Tyvaso inhalation solution, a pulmonary arterial hypertension treatment, with a firm fixed price of $14,693.62 and a completion date of May 16, 2024. The order is placed against United Therapeutics' Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB),...
- This is a firm fixed price delivery order awarded by the Department of Veterans Affairs (VA) to United Therapeutics Corp, a manufacturer of pharmaceutical goods. The contract, valued at $14,693.62, is for the supply of Tyvaso inhalation solution and related products to the VA's Veterans Integrated Service Network 21. United Therapeutics holds two national indefinite delivery/indefinite quantity (IDIQ) contracts with the VA, one valued at $50 million and the other at $198 million, which provide a...
- Pharmaceuticals and Drugs (FSS-61-IB)Master GSA Schedule
- 36F79720D0104Federal Supply Schedule
- 36F79720D0104-36C26024F0134Delivery Order
This is a firm-fixed-price delivery order awarded by the U.S. Department of Veterans Affairs (VA) to United Therapeutics Corp, a self-certified small disadvantaged business and manufacturer of pharmaceutical goods. The $88,161.72 order is for the supply of Tyvaso (treprostinil) inhalation solution, a medication used to treat pulmonary arterial hypertension. The contract is a task order placed against United Therapeutics' Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB). United Therapeutics holds several significant Indefinite Delivery Vehicles (IDVs) with the VA, including a $50 million Blanket Purchase Agreement and a $198 million FSS contract, which allow the VA to efficiently procure the company's specialized pharmaceutical products. This delivery order is part of the company's ongoing support of the VA's mission to provide quality healthcare services to veterans across the country.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $88.2k | 4/4/24 |